CLINICAL_TRIALS
trial_result
· 2019-12-02
Clinical Trial Update: Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence [Phase 2, Phase 3]
Summary
Clinical trial update on Gallium-68 PSMA-11 PET imaging in patients with biochemical recurrence of prostate cancer (Phase 2/Phase 3).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Francisco | Conditions: Prostate Cancer | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-12-02